Trial intelligence / Profile preview

INTERFANT-06 for infant acute lymphoblastic or biphenotypic leukemia

NL-OMON20078Recruiting

Sponsor
the different international study groups
Start
Jan 2006
Countries
1
01

Overview

Randomised, open-label trial in acute lymphoblastic leukemia (ALL) and mixed phenotype acute leukemia (MPAL) (2 arms), sponsored by the different international study groups. Primary endpoint: Event-free survival. Started Jan 2006; status: recruiting.

02

Conditions

acute lymphoblastic leukemia (ALL)mixed phenotype acute leukemia (MPAL)

Beyond the preview

Go deeper on NL-OMON20078.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20078.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call